Advancing Drug-Induced Liver Injury Detection
Drug-induced liver injury (DILI) remains a major challenge [...]
Mecwins Advances the Determination of pTau217 and pTau181 Biomarker Levels for Alzheimer’s Disease
© Juan Gärtner/stock.adobe.com At Mecwins, we are pushing [...]
Exploring the Future of Instrumentation at JCTI – Universidad Autónoma de Madrid
Last Thursday, our CEO Óscar Ahumada and our [...]
Breaking New Ground in Cardiology: Our Experience at “Nano solutions meet big challenges in health”
Last week, Mecwins had the opportunity to participate [...]
Mecwins Expands Global Reach with Innovative Biotech Services
Mecwins is pleased to announce its expansion into the [...]
